RELEASE LEGAL EMERGENCY AND DRUGS SERVICE LIMITED
YEAR ENDED 31 MARCH 2025
Release Drugs, The Law & Your Rights
Company Number 1966619
Charity Number 801118
Financial Statements Year End March 2025
Proudly supported by:
4, Cl 1/\RIT/\BLE / TRUSl
LONDON WAS Trust for London '!kid,q - UNfTY C. OPEN SOCIETY FOUNDATIONS 1 2 3 Looking back over the last year, it has been a tumultuous 12 months across the world, with political volatility, war and conflict, and, at times, a sense of perpetual crisis. Sadly, injustice and suffering have been more evident than ever. The UK has not been immune from these troubles and many public services and charitable organisations have experienced a tough year which, in turn, has been challenging for those people who rely on them. It is a matter of great pride that Release has continued its vital work in advocating for the rights of people who use drugs and for those who are adversely affected by drug laws and their policing. This has been the organisation's core focus since its creation in 1967 and the commitment to keep delivering its mission has never been stronger. During this year, our legal work has further grown and expanded, the Harm Reduction Hub has gone from strength to strength, and our research and policy work continues to be highly influential. We continue to make a real difference. None of this would be possible, of course, without the outstanding leadership of our Executive Director, Niamh Eastwood, and the hard work from the entire Release team. I am delighted to have the opportunity to thank them sincerely for everything they have done over the last 12 months. I am also fortunate to have been supported by my fellow Trustees who have made chairing the Board a privilege once again. Release is a very special organization that does vital work and we can be confident that, whatever challenges the world presents in the coming year, we will be able to step up and keep making a difference for those most in need. 4 I am writing this in November 2025, which is so often the way with these annual reports, and whilst this report reflects our work throughout 2024/25 it would be wrong to not acknowledge the significant loss in the field this year. Peter Krykant, our friend and Board member died in June of 2025. Peter was a drug user activist who campaigned tirelessly for the rights of people who use drugs at considerable cost to himself, and his loved ones, including his two sons who he adored. He opened the first safer injecting facility in the UK, when in 2020 during the height of the pandemic he took an old, converted ambulance into the centre of Glasgow and started an unsanctioned site. Glasgow's first sanctioned facility opened in January of 2025, and Peter's bravery is one of the reasons the UK now has facility. Peter will be deeply missed by all at Release and the wider harm reduction community, both nationally and internationally. Our thoughts, love and solidarity are with his family. Peter's death came shortly after my dear friend's Naomi Burke-Shyne. Naomi was the former Executive Director of Harm Reduction International, having previously worked at Open Society on access to justice for key populations. Through the work we became close friends. Then in 2018 HRI, Release and IDPC all moved Into offices together In London. Naomi had that unique gift of bringing people together, of creating alliances that would make the work more effective and just smarter. Her legacy is one of empowerment and solidarity. Across the world she created networks of lawyers working with marginalised groups, she helped build and cement the international community of harm reductionists through HRl's work and conferences, she pushed the human rights discussion in Geneva ensuring that the rights of those in the drugs trade was part of the UN human rights landscape, not just the UNs drug control framework. The whole harm reduction community misses her. Our love, thoughts and deep respect go to her husband, Matt, and to all her family. In the middle of this deep sadness, the work continued, and I want to thank our fantastic team for stepping in and supporting me and others during these difficult times. From the report you will read about how our legal services have expanded, how the Harm Reduction Hub has supported people to access harm reduction advice and equipment as well as importantly creating a space for care and solidarity, how our research work has deepened whilst also having to- once again -challenge government proposals that hurt some of the most excluded in society. This work Is only possible because of the commitment of the team - our solicitors, trainees and apprenticeships, drugs and harm reduction experts, the management team and our brilliant volunteers. Ultimately, though it is our clients and hub visitors who keep us grounded, the recognition that they are having to navigate systems that are so harmful and resistant to providing people with the basics, often at the expense of their legal rights, makes this fight so important. I have been struck by how hub visitors have created a community, which has been impossible for so many for so long, simply because space wasn't made available. I continue to hear in this field terms such as "complex service users" or ''hard to reach people," it Is the systems that are complex not people, and services that can be hard to reach -we will continue to challenge these systems, for the rights of all that we work with and for. Niamh Eastwood - Executive Director 5 The trustees, who are also Directors for the purposes of the Companies Act, present their report and the financial statements of the charity for the year ended 31 March 2025. Release is the national centre of expertise on drugs and drugs law and is an independent registered charity that was founded in 1967. The principal aims of the charitable company are to provide free and confidential legal, educational, welfare and expert drugs advice and information to any person, body, organisation or company In the areas of drug use, civil liberties, human rights and the criminal law. Release campaigns on issues that affect those we represent, including reform of the UK's current drug policy. The organisation provides free (at the point of delivery) legal and harm reduction services to Individuals/groups and free policy & educational publications. Our unique and specialist service activities include: The purpose (objective) of our services and programmes are to meet and deliver a public benefit through: advancing and supporting the health (physical and mental), economic, environmental and wellbeing needs of individuals experiencing substance use and dependency; those in recovery, and their families; and Develop programmes and provide support for marginalised groups that have/may come into contact with the criminal justice system because of drugs policing through the provision of information and publications adopting a harm reduction approach. Our drug policy campaigns are directed towards stimulating public awareness and debate, whilst offering alternative approaches to our current national drug policies. We also provide briefings to parliamentarians and have worked closely with the Global Commission on Drug Policy. been awarded the Specialist Quality Mark (SQM), Advice Quality Standard (AQS) and the 'Centre of Excellence' status by the London Legal Support Trust. Individual members of staff have professional memberships with The Solicitors Regulatory Authority, The Law Society, and the International Society for the Study of Drug Policy (ISSDP). Release is regulated by the Financial Conduct Authority (618823) to provide debt advice. The organisation is an NGO in Special Consultative Status with the Economic and Social Council of the United Nations, as well as being part of the Vienna and New York NGO Committees on Drugs. The Board of Directors believes that the charitable company should hold financial reserves because it has no endowment funding and is entirely dependent upon income from grants, sponsorship, donor funding and other income, which is inevitably subject to fluctuation from year to year. The Board of Directors believes that the minimum level of unrestricted reserves should be the equivalent of 6 months' operating costs, calculated and reviewed annually. The Board of Directors seeks to retain accumulated funds at the desired level in stages consistent with the company's overall financial position, the economic risk over the next 12 months as to its impact on sources of finance and its need to maintain and develop its charitable activities. Acquisitions and disposals of fixed assets during the year are recorded in the notes to the financial statements. 6 During the financial year, we had over 100 volunteers assisting our drugs and legal teams. Moving forward, we are actively preparing and creating volunteering and internship opportunities both through our service provision and links with academic institutions, as we recognise these opportunities help many people in developing their understanding, knowledge and skills around drugs and drugs law, which assist in gaining employment within the area, or furthering educational attainment. Release is extremely grateful to all of the volunteers during this testing year and continue to view their assistance as immeasurable. The Board of Directors has conducted its own review of the major risks to which the charitable company is exposed, and systems have been established to mitigate those risks. At every board meeting a standing item for consideration is safeguarding which considers the areas of client risk, and the appropriate responses and responsibilities to mitigate those risks. Our strategic plan (20203 to 2026) is also a standing item at each quarterly Board meeting, ensuring Trustees are reviewing areas of activity and diversification of funding. Internal risks are minimised by the implementation of strict financial procedures, clear lines of management and staff supervision and appraisals. A quarterly review of the risk register is carried out by senior management and the Board. ----- Start of picture text ----- 7 Quarterly board meetings- Executive Director/Joint Head of Legal Services/ Head of Drugs Services/ Head of Finance and Operations In attendance Annual General Meeting - Executive Director /Joint Head of Legal Services/ Head of Drugs Services/ Head of Finance and Operations in attendance Ad hoc meetings with board members and Executive Director and Head of Finance and Operations Fortnightly team meetings - all staff Fortnightly team meetings - drugs team Fortnightly team meetings - legal team Weekly meetings Executive Director - Head of Legal Services Weekly meetings Executive Director - Finance/Operations Weekly meetings Executive Director - Head of Drugs Services Weekly meetings with staff and volunteers The Memorandum and Articles of Association require that there be at least three trustees. Every trustee is appointed for a term of five years by a resolution of the trustees passed at a special meeting. In selecting a new trustee, the trustees take Into account the benefits of appointing a person who _Is able, by virtue of his or her personal or professional qualifications, to make a contribution to the pursuit of the objects or management of the charity. New trustees are required to spend an Induction day at the Release offices meeting with the Executive Director and other key staff, as well as attending one of the outreach programmes. The induction process also includes familiarisation with the organisation's work and history. Trustees are also expected to attend organisational strategy meetings as required, as well as the scheduled quarterly board meetings - one to include the AGM. Trustees are expected where possible to attend Release events and become involved with additional project work relevant to a trustee's skills/choice. Release continues to ensure it has diversified income streams to mitigate any funding shortfalls that could affect the organisation's activities. This diversification strategy has helped stabilise the organisation, although much of our funding remains tied to time-limited project and activity work. Nevertheless, Release has been successful in securing multi year programme and core funding-an achievement attributable to our reputation for developing, delivering, and collaborating on ne\¾ exciting, and impactful work, which continues to be recognised by funders. Looking ahead, the organisation will be developing new strands of work across different areas of Release, attracting additional funding streams and ensuring we remain relevant. One example is the new Oak Foundation-funded research project exploring the experiences of people who use drugs in hostels, shelters, and local authority accommodation. This project will examine how drug-related housing policies that lead to eviction or refusal to house contribute to homelessness. Ultimately, It aims to provide practical tools for housing providers and local councils to better support people who use drugs and are at risk of being unhoused. Similarly, funding secured from the Legal Education Foundation in 2024 has enabled us to deliver our new community care legal service. This investment supports training for our legal team so that more staff members are qualified in this area of 8 Net outgoing resources of the company for the year were £17,515 (2024- net outgoing resources- £209,600) details of which are given in the financial statements below. Free reserves at 31st March 2025 amounted to £207,309 (2024 - £322,319) as represented by unrestricted net current assets. Further details of funding sources and expenditure incurred to achieve the charity's key objectives are disclosed hereunder and in the notes to the financial statements. The Board of Directors (Trustees) are satisfied that in setting the objectives and planning the activities of Release these are fully compatible with the purposes of the charity and are fully compliant with the Charities Act 2011 public benefit requirement. The company operated satisfactorily during the year to 31 March 2025. Release's financial position for 2024-25 remained robust, supported by the continued development of key services including legal, drugs, and expert policy work-which has strengthened and diversified our income. We have been invited to join a growing number of regional tenders for our legal services and were successful in all but one. These contracts carry a minimum term of five years, with possible extensions subject to satisfactory performance. In addition to expanding the reach of our legal services, we secured-for the first time-a regional contract to deliver our drugs advocacy programme, working with peers and service providers in Bristol. Release looks forward to developing this work further. Our expertise In harm reduction and drug policy also led to several consultancy engagements to draft and produce policy papers for international bodies. Throughout the year, we maintained close oversight of expenditure to ensure maximum benefit to the organisation and its beneficiaries. The principal alms of the company are to provide free and confidential legal, educational, and welfare advice and information to any Individual or organisation In the areas of drug use, civil liberties, human rights, and criminal law. 9 YEAR ENDED 31 MARCH 2025 The legal team continued to deliver legal outreach services across London, and via our now established 'virtual' services· available in Maidenhead, Rotherham, Reading, Stoke on Trent, Hull, Stockton on Tees, and Lancashire. The geographic deployment of the virtual services was intentional, with some areas targeted based on multiple deprivation Indicators and The London services continued to be available to all clients of the 14 host centres in the following London boroughs: Brent, Camden, Haringey, Ealing, Greenwich, Islington, Lambeth, Newham, Tower Hamlets, and Waltham Forest. During the 12-month period we assisted-1,545 clients with 2712 separate legal issues - 15% (n.231) presented as homeless •. From the aforementioned services, we recently secured multi-year contracts to provide legal outreach clinics in Lancashire, providing services in Preston, Burnley and Lancaster. The provision of this means we can support more clients in the North of the UK, who otherwise have limited scope in accessing legal support. Our specialist representation service for social security tribunals, funded by the Trust for London, achieved a 95% success rate for our London clients. In the last year alone, we have secured approximately £296,980 in backdated benefit payments for our clients. We were successfully awarded a legal aid contract for Community Care and Public law in September 2024. Through obtaining legal aid contracts, we have been able to deliver services for young people aged 16 - 25, as well as providing legal support and representation fo·r clients with disabilities and complex health needs. Our legal aid provision complements our existing London services, providing holistic and different routes for clients' rights to housing, social care support and mental health services to be explored, safeguarded and challenged. Through developing legal aid work, we have been able to take on referrals of cases through London and virtual services we provide outreach work at, in addition to our existing stream of work through these services. The types of cases we have taken on and successfully settled include challenging gatekeeping of providing assistance to homeless clients without access to online portals to submit homelessness applications; receiving care packages from adult social care; obtaining accommodation for individuals with care needs and no recourse to public funds, and defending young care leavers who were given closure orders to leave their property. Since October 2024, we have taken on 35 community care cases and 6 public law cases. Through developing legal aid and expanding work into these arears, as an organisation we hope to inspire our upcoming legal advisors and solicitor apprentices to specialise into social welfare, whilst also upholding the rights of our clients. The development of both community care and public law di;!partments are led by Niresha Umalchelvam. The development of staff, including training, resources and materials to complement learning and expertise for our staff, has been possible through funding received by a grant from Legal Education Foundation. Our Immigration service has now been developed by Liam Carmody, and with funding from the City Bridge Trust has been implemented In two CGL services In London. We are also about to offer this service to all of the drug and alcohol service providers we operate within in London. This work has only been possible with the financial and technical support of Refugee Action. Whilst not falling within the financial year 2024 to 2025, we wanted to share a recent acknowledgement of Release's recognised work in this area. Our legal team won an award at WYN Legal's Pro Bono and Parliamentary Reception at the House of lords during Pro Bono Week 2025, for 'outstanding' commitment to Pro Bono initiatives. We also continue to have strong links with universities to provide legal internships for law students interesting In gaining experience In social welfare, immigration, community care and public law. 10 RELEASE LEGAL EMERGENCY AND DRUGS SERVICE LIMITED The drug advocacy service is delivered by the Head of Drugs Service, a Drugs Advisor and Advocate, and a Drugs Support Advisor and NSP Specialist who provide one-off harm reduction advice to people through Release's national helpline, anonymous email inbox, and in-person via the Harm Reduction Hub. People contacting the drugs service can also receive bespoke advice and advocacy for accessing drug treatment services, ensuring their voice and needs are centred in their care. The helpline and email advice components of the Drugs service are partially supported by funding provided by Ethypharm. This year we secured a contract in Bristol to offer a regional advocacy service, with the aim of recruiting a local peer advocate who can offer face to face local advocacy with the support of the Drugs Advisor and Advocate in London. The service begins operation in 25/26. In 24/25, the Harm Reduction Service continued to provide a needle and syringe programl'{le, with a contract from London Borough of Tower Hamlets (LBTH) to support staff time, volunteer expenses and inventory. The hub operates from 14:00 to 17:00 Monday to Thursday with combinations of staff and volunteer staffing. Then Friday, Saturday, and Sunday, shifts are set dependent on volunteer availability, and service hours are advertised one month ahead of when those weekends are set for. Friday shifts generally fall from 19:00 to 22:00 and on Saturday and Sunday we operate between 16:00 and 19:00. These shifts are collectively referred to as 'off-hours shifts' and are run by contracted 'Team Leaders.' The space provides a range of services for people who use drugs as well as anyone In the community, prioritising those most vulnerabilised through the direct lack of appropriate services or those who experience over-policing or forms of surveillance as barriers to accessing mainstream services. Release continues to provide a two-part advocacy guide to support people accessing drug treatment, free of cost to directly impacted individuals and grassroots organisations. This guide can be used for both self and peer advocacy, and It contains; the principles of advocating, an introduction to national guidelines including "Drug misuse and dependence; UK guidelines to follow for overcoming different drug treatment obstacles. In the final. sections, all of those obstacles included are ones which people have previously asked Release to support them with, via our national helpline. Using the advocacy guide we have launched a training programme for drug service workers, housing workers, and drug treatment service users who want to better understand their rights within the treatment system. Thus far, we have found that our trainings receive very positive fe dback from attendees, who often were unfamiliar with the UK guidelines on clinical management prior to our training, and who had all experienced some of the obstacles we named in our guide. Our advocacy work helps to raise awareness and make the relevant parts of those guidelines more easily accessible to people who use drugs and relevant professionals. Release's Head of Drugs has been involved in a number of research projects with the London School of Hygiene and Tropical Medicine. One stream of work is around the care people who are on opioid substitute treatment (OST) receive when they are in hospital, with the aim of improving access to medications and ensuring care Is centred in dignity and support. The other project we are involved in relates to the provision of drug-using equipment for people who use crack cocaine. Currently there is very little that UK drug services can offers those who use this drug, and so expanding the types of equipment offered to include safer inhalation pipes is a great way to connect with people using crack cocaine specifically as well as an opportunity to offer a wider range of support and health services to people using drugs collectively. The Drugs Monitoring Network (DMN) that was established In 2020 to collect Information from people who use drugs and harm reduction workers about changes In the drugs supply continued to report over the last 12 months. The information provided by the DMN informs national alerts by the Office for Health Improvement and Disparities (OHIO), and Release's own harm reduction work. With an Increasingly toxic drug supply, this work Is crucial to ensuring that we know what Is happening as close to real time as possible. 11 During 2024/25 we received just over 2,000 contacts through a combination of telephone calls, emails, and online submissions seeking support for a range of issues. Email and online enquiries continue to be a medium for those seeking advice, with over 20% of enquiries submitted through these 2 channels (all are responded to within one working day). People accessing the helpline services continue to seek advice on criminal proceedings involving drugs, employment issues involving drug tests and drug use, advice on treatment issues including a reduction in opiate substitute prescribing and onerous conditions attached to treatment. The team at Release view the helpline as an important source of information that ensures that we keep up to date with patterns of drug consumption and changes in the market, so whilst largely unfunded it is critical that we continue to provide the service both for our own professional development and for the fact it is needed. Release was delighted to secure a 4-year grant from the Oak Foundation to explore the experiences of people who use drugs who have lost accommodation linked to drug-related housing policies or have been blocked from securing stable accommodation. The first part of the project is a research piece that will interview people, capturing their lived experience and highlighting the harms of punitive housing policies. The team, led by our new Research Lead, Cornelis Rijneveld, will be supported by participatory researchers who have experienced housing tiarms. We will also put a spotlight on pockets of good practice across the UK. The second part of the project, which will commence In 2027, will be to develop good practice guides and materials to support those working in the housing sector to ensure services are working in an inclusive manner. Release has worked Independently and in partnership with other NG Os to provide expert input to a range of committees and consultations. Our work has spanned local, national and international levels. We are always focussed on ensuring policy makers are provided with the evidence to support public health and human rights approaches to drug use, the most up to . date information on drug use and its Impacts, and the real-life impact of their policies on our client group. We also respond to legislative changes that are not directly related to drug policy but to other legislative changes that have a direct and disproportionate impact on people who use drugs. This work Is reactive to political and social movements, and this year has focused primarily on changes In anti-social behaviour policing and changes to benefits entitlement. Policy work: Advisory Council on the Misuse of Drugs (ACMD): Call for evidence on ketamine. • Crime and Policing Bill: Submission at Committee Stage. Department for Work and Pensions: Consultation response to Pathways to Work Green Paper on benefit reform. London Borough of Haringey: Joint submissions on proposed Public Spaces Protection Order with liberty and Museum of Homelessness Police and Criminal Evidence Act 1984 (PACE) and the PACE Codes of Practice: Submission to public consultation. Committee on Economic, Social and Cultural Rights (CESCR): Joint oral evidence with RATS, HRI, and IDPC Justice Committee: Joint submission on drugs in prison with INQUEST and Professor Rob Ralphs. Scottish Affairs Committee: Submission on the Thistle project (Glasgow's OCR). Equality and Human Rights Commission (EHRC): Submission on gender guidance. Presented evidence to the House of Lords and the Scottish Home Affairs Committee. Provided a briefing paper on Drug Consumption Rooms (DCRs) to the Icelandic Government, in partnership with Queen's University Belfast. Release's work was widely cited in the Scottish Affairs Committee's published report on DCRs. • Delivered a briefing for MPs at the Westminster Hall Debate on the prevention of drug-related deaths. 12 As outlined below Release expertise has resulted in us working on international policy papers for the Global Commission on Drugs and UNAIDs. The Release website remains an important resource for people seeking information about drugs and the law. Between 1 April 2024 and 31 March 2025, it attracted 344,000 unique visitors. In a shift from previous years, the most viewed pages were within our Drugs A-2 section, demonstrating that people are actively seeking credible, reliable information on drugs alongside harm reduction advice. Content on the site is frequently updated to reflect changes in the law relevant to people who use drugs, as well as to share policy developments connected to our work. Our social media presence has also evolved in response to the changing digital landscape. The organisation has stepped back from X and is now focusing on sharing content through lnstagram and Bluesky Since 2014, Release has delivered Drug Policy Fellowship Programmes for professionals working in sectors related to drug policy and harm reduction. The core aim of the programme is to share learning, build knowledge, and exchange strategies for developing drug policies grounded in public health and human rights. For more than a decade, we have welcomed fellows from countries across Latin America, Asia, and Africa. Each iteration of the Fellowship expands the growing pool of high-profile drug policy advocates globally, many of whom do not work full-time on drug-related issues but operate in closely connected fields. This year, we welcomed four outstanding fellows from Ghana, South Africa, and Kenya. During their time in the UK, the fellows met with NGOs working in drug policy, harm reduction, and human rights. Release continues to provide expert support to NGOs in other countries working to advance efforts to decriminalise people who use drugs: Last year, we offered advice to colleagues in Malaysia, Brazil, Iceland, and Ireland. Release's Executive Director, along with one of our apprentice solicitors, Fenelia Sentance, served as technical consultants to the Global Commission on Drug Policy, co-authoring its 2024 report ——— Bevond Punishment: From Criminal Justice Responses to Drua Policv Reform. We were also delighted to join a consortium with the International Network of People who Use Drugs (INPUD) and the International Centre on Human Rights and Drug Policy, which successfully tendered to draft UNAIDS' technical guidance on drug decriminalisation. Release's online international platform, TalkingDrugs-a global multilingual news and analysis platform covering drug policy developments-continued to report on drug policy and harm reduction issues from around the world. The website revamp in 2023/24 led to a modest increase in traffic between April 2024 and March 2025, with 162,000 individual visitors, a 5% rise on the previous year. This follows the significant growth seen in 2023/24, when readership increased by 267%. 13 ----- Start of picture text ----- 0 .. ----- Start of picture text ----- Once again, Russian readers were our largest single-country audience, representing 13% of total visitors. Thanks to avoiding a news block in Russia and the work of excellent language-specific editors, TalkingDrugs has become a key source of information for drug policy advocates there. We also saw notable growth in our Japanese audience, largely driven by interest in a story about crack cocaine use in Brazil. Across social media, TalkingDrugs maintains a strong brand identity and consistent posting schedule. On lnstagram, our audience has grown to 6,500 followers, a 20% increase compared with the previous year. The platform continues to rely on a mix of paid and unpaid writers-supporting emerging researchers to develop their skills while commissioning established journalists to reinforce TalkingDrugs' reputation as an authoritative source of drug policy analysis. Looking ahead, we plan to evolve TalkingDrugs into more of a community hub where other NGOs working in drug policy and harm reduction can share updates, news, and events. This approach recognises the increasingly limited space available within both digital and mainstream media. Release staff provided comment and interviews to all the major newspapers including the Guardian, the Times, the Independent and the Evening Standard. Local press also sought comment on issues related to drugs, drug policy and harm reduction. TV appearances were made by the staff on various news programmes including ITV and Channel 5. The newly launched Harm Reduction Hub was featured in a Guardian short. Staff continued to participate in conferences and seminars related to harm reduction and drug policy both internationally and nationally. Release staff provided evidence to several UN treaty bodies and agencies, highlighting the UK experience and the human rights abuses and failing related to drug policies. Oral testimony was provided to the Human Rights Council, Committee on the Elimination of Racial Disparities, the Committee on Economic, Social and Cultural Rights. Release has achieved the Cyber Essentials certificate and further to this the organisation is also protected by Microsoft Account Guard, which covers the entire !CT estate of the organisation. Release would like to thank all of our funders who have supported us through the last 12 months. 14 YEAR ENDED 31 MARCH 2025 THE TRUSTEES The trustees who served the charity during the period were as follows: Natasha Dhumma Roger Galland Donnchadh Greene Andrew Horne (Treasurer) Peter Krykant Amber Marks David Rowntree Professor Toby Seddon (Chairperson) lmani Robinson 15 The trustees (who are also the directors of Release Legal Emergency and Drugs Service Limited for the purposes of company law) are responsible for preparing the Trustees Annual Report and the financial statements In accordance with applicable law and United Kingdom Accounting Standards (United Kingdom Generally Accepted Accounting Practice). Company law requires the trustees to prepare financial statements for each financial year which give a true and fair view of the state of affairs of the charitable company and of the incoming resources and application of resources, Including the income and expenditure, of the charitable company for that period. In preparing these financial statements, the trustees are required to: select suitable accounting policies and then apply them consistently; observe the methods and principles in the Charities SORP; make Judgements and estimates that are reasonable and prudent; state whether applicable UK Accounting Standards have been followed, subject to any material departures disclosed and explained In the financial statements; prepare the financial statements on the going concern basis unless It Is Inappropriate to presume that the charitable company will continue In operation. The trustees are responsible for keeping proper accounting records that disclose with reasonable accuracy at any time the financial position of the charitable company and enable them to ensure that the financial statements comply with the Companies Act 2006. The trustees are also responsible for safeguarding the assets of the charitable company and hence for taking reasonable steps for the prevention and detection of fraud and other Irregularities. In so far as the trustees are aware: there Is no relevant examination information (information needed by the charitable company's independent examiners In connection with preparing their report) of which the charitable company's Independent examiners are unaware, and the trustees have taken all the steps that they ought to have taken to make themselves aware of any relevant examination Information and to establish that the charitable company's Independent examiners are aware of that Information. This report has been prepared In accordance with the special provisions for small companies under Part 15 of the Companies Act 2006. Approved by the board on 15/12/25 and signed on their behalf by: Professor Toby Seddon Chairperson of Trustees 16 I report to the trustees on my examination of the accounts of Release Legal Emergency and Drugs Service Limited for the year ended 31 March 2025. RESPECTIVE RESPONSIBILITTES OF TRUSTE S AND EXAMINER As the charity's Trustees of Release Legal Emergency and Drugs Service Limited (and also Its directors for the purposes of company law) you are responsible for the preparation of the accounts in accordance with the requirements of the Companies Act 2006 ('the 2006 Act'). The charity's trustees consider that an audit Is not required for this year under section 144 of the Charities Act 2011 (the Charities Act) and that an independent examination ls needed. Having satisfied myself that the accounts of Release Legal Emergency and Drugs Service Limited are not required to be audited under Part 16 of the 2006 Act and are eligible for Independent examination, I report In respect of my examination of your charity's accounts as carried out under section 145 of the Charities Act 2011 ('the 2011 Act'). In carrying out my examination I have f[o] llowed the Directions given by the Charity Commission under section 145(S)(b) of the 2011 Act. INDEPENDENT EXAMINER'S STATEMENT Since Release Legal Emergency and Drugs Service Llmlted's gross Income exceeded £250,00 your examiner must be a member of a body listed in section 145 of the 2011 Act. I confirm that I am qualified to undertake the examination because I am a fellow member of the As ociation of Charity Independent Examiners, which is one of the listed bodies. I have completed my examination. I confirm that no matters have come to my attention In connection with the examination giving me cause to believe: 1. accounting records were not kept In respect of Release Legal Emergency and Drugs Service Limited as required by section 386 of the 2006 Act; or 2. the accounts do not accord with those records; or 3. the accounts do not comply with the accounting requirements of section 396 of the 2006 Act other than any requirement that the accounts give a 'true and fair view' which Is not a matter considered as part of an independent examination; or 4. the accounts have not been prepared In accordance with the methods and principles of the Statement of Recommended Practice for accounting and reporting by charities [applicable to charities preparing their accounts In accordance with the Financial Reporting Standard applicable In the UK and Republic of Ireland (FRS 102)). I have no concerns and have come across no other matters In connection with the examination to which attention should be drawn In this report in order to enable a proper understanding of the accounts to be reached. FCIE Independent Examiners Ltd The Grain Store, Hills Barns Appledram Lane South Chichester PO207EG Date: 17 December 2025 17 RELEASE LEGAL EMERGENCY AND DRUGS SERVICE LIMITED
STATEMENT OF FINANCIAL ACTIVTIES
Income and Endowments from:
Donations, Grants and Legacies
Charitable Activities
Other Trading Activities
Investments
Other
Total
Expenditure on:
Raising Funds
Charitable Activities
Other
Total
Net income/(expenditure)
Transfers between funds
Other recognised gains/losses
Gains/(losses) on revaluation of fixed assets
Gains/(losses) on investment assets
Net movement in funds
Reconcillation of funds:
Total funds brought forward
Total funds carried forward
Notes
2a
2b
2c
2d
2e
За
3b
3с
10,11
YEAR END 31 MARCH 2025
Designated
Funds
2024/25
TOTAL
2023/24
83,024
271,182
121
7,816
362,143
18,650
461,880
623
481,153
(119,010)
(137)
:
(119,147)
334,729
215,582
Restricted
Funds
171,415
2,047
335
173,797
41,255
149,828
191,083
(17,286)
137
(17,149)
36,763
19,614
397,830
27,013
-
424,843
12,600
293,462
306,062
118,781
:
118,781
69,927
188,708
652,269
300,242
456
7,816
960,783
72,505
905,170
623
978,298
(17,515)
:
(17,515)
441,419
423,904
401,001
249,161
119
7,666
1,513
659,460
26,489
842,571
869,060
(209,600)
:
(209,600)
651,019
441,419
Movements on all reserves and all recognised gains and losses are shown above. All of the organisation's operations are classed as continuing.
The notes on pages 20 to 29 form part of these financial statements.
18 The directors are satisfied that for the year ended on 31st March 2025 the charitable company was entitled to exemption from the requirement to obtain an audit under section 477 of the Companies Act 2006 and that no member or members have required the company to obtain an audit of Its accounts for the year In question In accordance with section 476 of the Act. However, In accordance with section 145 of the Charities Act 2011, the accounts have been examined by an Independent Examiner whose report appears on page 17. The directors acknowledge their responsibility for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts. The accounts have been prepared In accordance with the provisions In Part 15 of the Companies Act 2006 applicable to companies subject to the small companies regime and In accordance with Accounting and Reporting by Charities: Statement of Recommended Practice applicable to Charities preparing their accounts In accordance with FRS 102 (effective 1 January 2019) - (Charities SORP (FRS 102)) and the Charities Act 2011. The directors acknowledge their responsibility for ensuring that the company keeps proper accounting records which comply with section 386 of the Act and for preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of the financial year and if its profit and loss for the financial year in accordance with the requirements of sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to accounts, so far as applicable to the company. Print Name: 19 RELEASE LEGAL EMERGENCY AND DRUGS SERVICE LIMITED
NOTES TO THE FINANCIAL STATEMENTS
YEAR END 31 MARCH 2025
Basis of preparation:
The accounts have been prepared in accordance with the provisions in Part 15 of the Companies Act 2006 applicable to companies subject to the small
companies regime and in accordance with Accounting and Reporting by Charities: Statement of Recommended Practice applicable to Charities
preparing their accounts in accordance with FRS 102 (effective 1 January 2019) - (Charities SORP (FRS 102)) and the Charities Act 2011.
Advantage has been taken of Section 395(5) of The Companies Act 2006 to allow the format of the financial statements to be adapted to reflect the
special nature of the charity's operation and in order to comply with the requirements of the SORP.
elease Legal Emergency and Drugs Service Limited meets the definition of a publlc benefit entity under FRS102. Assets and labilities are intiall
ecognised at historical cost unless otherwise stated in the relevant accounting policy notes
Going concern
Preparation of the accounts is on a going concern basis. The Trustees are of the view that the level of reserves will support the charity going forward.
Changes to accounting estimates
No changes to accounting estimates have occurred in the reporting period.
No material prior year errors have been identited in the reporting period.
• ACCOUNTING POLICIE:
he particular accounting policies adopted are set out belon
Income
Recognition of Income
These are included in the Statement of Financial Activities (SOFA) when:
• the charity becomes entitled to the income;
the morelay she and thare reset wile the resources, and
Offsetting
There has been no offsetting of assets and liabilities, or Income and expenses, unless required or permitted by the FRS 102 SORP OF FRS 102.
Grants and Donations
Grants and donations are only included in the SoFA when the general income recognition criteria are met (5.10 to 5.12 FRS 102 SORP).
Revenue and Capital Grants
Tax reclaims on Donations and Gifts
Gift Aid receivable is included in income when there is a valid declaration from the donor. Any Gift Aid amount recovered on a donation is considered
otherwise that eft and is seated as an adition to the same fund as the hitl donation unless the donor or the terms of the appeal have specied
Contractual Income and Performance Related Grants
This is only included in the SoFA once the charity has provided the related goods or services or met the performance related conditions.
Legacies
Legacies are included in the SOFA when receipt is probable, that is, when there has been grant of probate, the executors have established that there
are sufficient assets in the estate and any conditions attached to the legacy are either within the control of the charity or have been met.
The charity as not received govement grants in the reporting period.
Donated goods
Donated goods are measured at fair value (the amount for which the asset could be exchanged) unless impractical to do so
Donated Services and Facilities
Donated services and facilities are included in the SOFA when received at the value of the gift to the charity provided the value of the gift can be
measured reliably.
You value of any voluntary l received sant indude the couns but described in the rector' anual report.
20 RELEASE LEGAL EMERGENCY AND DRUGS SERVICE LIMITED
NOTES TO THE FINANCIAL STATEMENTS
YEAR END 31 MARCH 2025
Income from interest, royalties and dividends
This is included in the accounts when receipt is probable and the amount receivable can be measured reliably.
Insurance claims
Insurance claims are only included in the SoFA when the general income recognition criteria are met (5.10 to 5.12 FRS 102 SORP) and are included as
an Item of other Income in the SoFA.
Expenditure and liabilities
Where possible, expenditure is allocated specifically to the relevant activities for which it is incurred. Where costs cannot be directly attributed they
have been allocated to activities on a basis consistent with the use of the resources. Overhead costs in the statement of financial activities are
apportioned on the basis of staff time spent on each activity.
Liability recognition
Liabilities are recognised where it is more likely than not that there is a legal or constructive obligation committing the charity to pay out resources and
the amount of the obligation can be measured with reasonable certainty.
Governance Costs
Support costs have been allocated between governance costs and other support. Governance costs comprise all costs involving public accountability of
the charity and its compliance with regulation and good practice.
Grants with Performance Conditions
Where the charity gives a grant with conditions for Its payment being a specific level of service or output to be provided, such grants are only
recognised in the SOFA once the recipient of the grant has provided the specified service or output.
Grants Payable without Performance Conditions
Where there are no conditions attaching to the grant that enables the donor charity to realistically avoid the commitment, a lability for the full funding
obligation must be recognised.
Employee benefits
Short term benefits including holiday pay are recognised as an expense in the period in which the service is received.
Redundancy cost
The charity made no redundancy payments during the reporting period.
Deferred income
No material item of deferred income has been included in the accounts.
Legal status of the charity
The charity is a company limited by guarantee and has no share capital. In the event of the charity being wound up, the liability in respect of the
guarantee is limited to f1 per member of the charity.
Stocks and work in progress
Stocks held for sale as part of non-charitable trade are measured at the lower or cost or net realisable value.
Fixed Assets
Tangible fixed assets for use by the charity
These are capitalised if they can be used for more than one year, and cost at least E500. They are valued at cost or, if gifted, at the value to the charity
on receipt.
Depreciation is calculated at a rate to write off the cost of tangible fixed assets on a straight line basis over their estimated useful lives. The rates
applied per annum are as follows:
Fixtures, Fittings and Equipment
straight line basis
25%
21 NOTES TO THE FINANCIAL STATEMENTS
2. INCOME AND ENDOWMENTS FROM:
a) Donations, Grants and Legacies
Donations:
Other Small Donations
Donation received for funeral
Grants:
AB Charitable Trust
Access to Justice
Community National Lottery
Disrupt
Esmee Foundation
Geneva Institute
R.A.T.S
Legal Education Foundation
London Borough Tower Hamlets
London Legal Support Trust
Oak Foundation
Open Society Foundation
Refugee Action
Trust for London
Legacies
b) Charitable Activities
Consultancy Training and Conferences
Expert Witness Income
Fundraising Income
Hosting and Support Income
Legal Surgery Income
Outreach Programmes
Project Income
c) Other Trading Activities
Online Merchandise
d) Investments
Dividends & Interest
e) Other
Recharge of Expenses
Sundry & Miscellaneous Income
•
RELEASE LEGAL EMERGENCY AND DRUGS SERVICE LIMITED
Note
Unrestricted
Funds
€
Designated
Funds
2,119
5,000
83,024
2,670
21,000
235,837
10,000
1,675
271,182
121
121
7,816
7,816
2,141
7.200
49,78
102,286
171,415
308
1,739
• •
2,047
335
335
:
Restricted
Funds
€
YEAR END 31 MARCH 2025
TOTAL
2024/25
€
TOTAL
2023/24
€
:
16,410
16,481
39,071
397,830
:
650
26,363
27,013
:
652,269
2,978
1,739
21,650
235,837
10,000
28,038
300,242
456
456
7,816
7,816
:
401,001
17,893
1,792
15,257
18,650
172,711
10,000
12,858
249,161
119
119
7,666
7,666
218
1,295
1,513
22 RELEASE LEGAL EMERGENCY AND DRUGS SERVICE LIMITED
NOTES TO THE FINANCIAL STATEMENTS
3. EXPENDITURE ON:
a) Raising Funds
Consultancy Fees
Fundraising and Events
Hospitality
Marketing
Products - merchandise
Staff Costs - Fundraising
b) Charitable Activities
Furthering charity alms.
Bank Charges
Donations passed on for funera
Harm Reduction Hub
Hospitality (UK)
Licences & Permits
Memberships and Subscription:
Open Society Foundation - Feilowship programme costs
Printing and Reproduction
Professional Fees
Project Costs
Publications & Resources
Repairs and Maintenance
Staff Costs
Training & Certificatior
Volunteers Expense:
Support Costs
Bad Debts
Bank Charges
Computer and Internet
Conference Costs
Depreciation Expense
Insurance Expense
Miscellaneous
Non-Recoverable VAT
Office Expenses and Rent
Other Premises Costs incl Utilities
Postage and Couriers
Telephone
Travel
Charity governance
Independent Examination & Accountancy Fees
Legal & Professional Fees
Staff Costs
) Other
Bad and Doubtful Debts
Sundry Expenses
Note
Unrestricted
Funds
€
2,370
760
2,102
1,104
12,314
18,650
224
BEN ×888.
Designated
Funds
40,466
60
729
41,255
Restricted
Funds
12,600
12,600
YEAR END 31 MARCH 2025
TOTAL
2024/25
€
55,436
760
2,102
1,164
729
12,314
72,505
TOTAL
2023/24
6,987
1,910
2,143
3,302
12,147
26,489
257,767
2,790
22,858
1,654
21,173
622
461,880
605
18
623
149,828
:
293,462
ErE
905,170
605
18
623
842,571
:
=
• RELEASE LEGAL EMERGENCY AND DRUGS SERVICE LIMITED
NOTES TO THE FINANCIAL STATEMENTS
YEAR END 31 MARCH 2025
4. SUPPORT AND GOVERNANCE COSTS
Office & administration
Independent examiners fees
Legal & Professional Fees
Staff Costs
Support
12,286
:
Governance
Total
121,286
1,710
1,000
12,314
15,024
121,286
1,710
1,000
12,314
136,310
5. DETAILS OF CERTAIN TYPES OF EXPENDITURE
Independent examiner's fees
Assurance services other than audit or independent examination
Tax advisory fees
Other fees (for example: financial advice, consultancy, accountancy services) paid to the independent examiner
6. TANGIBLE FIXED ASSETS
2024/25
1,950
:
2023/24
1,890
:
eneral Fund Restricted Fu
Equipment
Equipme
€
163,609
Total
Cost
Additions
Transfers
Cost at
Depreciation
Charge
On Disposals
Depreciation at
Net Book Value
Net Book Value
01-Apr-24
163,609
31-Mar-25
01-Apr-24
163,609
151,199
4,137
31-Mar-25
155,336
31-Mar-25
8,273
31-Mar-24
12,410
163,609
151,199
4,137
159335
8,273
12,410
The annual commitments under non-cancelling operating leases and capital commitrfents for the next financial year are as follows:
31st March 2025 : Property Lease €75,000
31st March 2024 : Property Lease £75,000
7. CASH AT BANK AND IN HAND
Unresticted Derinated
Fund
Restricted
Fund
Cash at Bank and in Hand
137,970
137,970
19,614
19,614
188,708
188,708
Total
31-Mar-25
€
346,292
346,292
Total
31-Mar-24
€
434,492
434,492
8. DEBTORS AND PREPAYMENTS
Unrestricted Unrestricted
Fund
Restricted
Fund
€
Prepayments
Trade Debtors
Prepaid Expenses
VAT Refund
Employee Loan
18,750
72,516
250
1,234
2,080
94,830
Total
31-Mar-25
€
18,750
72,516
250
1,234
2,080
94,830
Total
31-Mar-24
€
18,750
786
2,288
21,824
24 RELEASE LEGAL EMERGENCY AND DRUGS SERVICE LIMITED
NOTES TO THE FINANCIAL STATEMENTS
YEAR END 31 MARCH 2025
9. CREDITORS AND ACCRUALS: AMOUNTS FALLING DUE WITHIN ONE YEAR
Trade Creditor
ndependent Examiners Fee
Other Creditors
PAYE, NI and Student Loan Deductions
10. DESIGNATED FUNDS - CURRENT YEAR
Balance
02-A0-24
Harm Reduction Fund
HRH Event Fund
Disrupt
Open Society Foundation:
Eastern Europe Project Fund
International Project Fund
Community Care (Legal Education Fdn)
34.763
36,763
10a) DESIGNATED FUNDS - PREVIOUS YEAR
Balance
Unresnidted
Designated
Fund
Restricted
Fund
€
Total
31-Mar-25
Income
12,300
2,223
7,200
173,798
Income
3,025
1,950
6,687
13,829
25,491
3,025
1,950
6,687
13,829
25,491
Purchase of
Expenditure
Fixed Assets
Expenditure Transfer Btw
(Depreciation)
Funds
:
:
(14,437
(2,223)
(414)
(94,264)
(34,763)
(44,983)
(191,084)
:
:
137
:
:
137
Purchase of
Expenditure Expenditure Transfer Btw
Fixed Assets
(Depreciation)
Funds
Total
31-Mar-24
€
7,700
1,890
2,699
15,018
27,307
31-Mar-25
3,023
4,805
19,614
Balance
31-Mar-24
rm Reduction Fu
y Fuent Fut
Open Society Foundation Fund
Asian Fellowship Fund
Talking Drugs Fund
International Project Fund
Gary Sutton Legacy Fund
Funeral donation passed on
10,674
4,743
1,792
1,049
58,908
3,000
80,166
(8,674)
(4,743)
(4,405)
(17,780)
(49,393)
(24,145)
(12,500)
(3,000)
(124,640)
4,405
15,988
48,344
-
12,500
2,000
:
34,763
..
:
81,237
35,765
All expenditure has been spent on the purposes designated by the Trustees. Designated funds are wholly represented by cash reserves of the charity.
The Trustees plan to spend the balances held at 31st March 2024 on international projects and harm reduction projects as shown above.
25 RELEASE LEGAL EMERGENCY AND DRUGS SERVICE LIMITED
NOTES TO THE FINANCIAL STATEMENTS
11. RESTRICTED FUNDS - CURRENT YEAR
YEAR END 31 MARCH 2025
Balance
02-Ap-24
18,300
18,000
Income
Purchase of Expenditure
Fixed Assets
Transfer In Transfer Out
€
Lottery Fund
Geneva Institute
I-Host
Inpud (Unaids)
Justice Fellowship Fund
Legal Outreach Services
Oak Foundation
Refugee Action
R.A.T.S
Trust for London
116,740
18,000
12,858
13,505
65,000
11,025
131,932
16,481
231
39,071
424,843
(113,967)
(36,000)
(12,858)
(13,505)
(45,000)
(11,025)
(24,547)
(16,481)
(231)
(32,449)
(306,062)
-
:
Balance
31-Mar-25
€
21,073
20,000
30,432
107,385
9,817
188,708
:
3,195
69,927
2024/25: The transfers represent:
There were no transfers between funds in 2024/25.
The Restricted Project Funds comprise of grant funding received for the specific projects that Release administers. These funds are as follows:
Lottery Fund - this funding is granted for legal welfare services
Geneva Institute - this funding is for the Agreement for Global Commission on Drug Policy: Report 2024.
HOST (Improving Hospital Opioid Substitution Therapy: the funding is for the Implementation and assessment of an intervention to reduce late
presentations, discharges against medical advice and repeat admissions among people who use oplolds.
lustice Fellowship - this funding is the help accessing legal support grant
LEGAL OUTREACH SERVICE CONTRACTS WITH:
Camden & Islington NHS Foundation
Change, Grow, Live (CGL) in Camden, Ealing, Newham & Reading
Cranstoun (Maidenhead)
Royal Borough of Greenwich (Woolwich & Greenwich)
South London & Maudsley NHS Foundation (Lambeth)
V-l-A (Brent)
We are With You (Rotherham & Stoke-on-Trent)
GRANT FUNDING LEGAL SERVICE
City Bridge Trust has provided 3-years of funding to develop our immigration provision across London by focussing on people that are homeless and
attending alcohol and drug treatment centres.
London Legal Support Trust has designated Release as one of their Centres of Excellence (CoEx) programme and is a support model for high-
performing free legal-advice agencies in London and the home counties.
Refugee Action - The aim of the Good Practice and Partnerships (GPP) Team is to strengthen the refugee and asylum sector by building capacity and
facilitating collaboration between organisations. The Migrant Justice Greater London Project aims to increase access to justice within London
communities by enabling organisations to cultivate their own immigration advice skills.
Oak Foundation has awarded a four-year research grant, effective October 2024, dedicated to improving housing stability outcomes for individuals
experiencing homelessness and substance use disorders. The research initiative aims to advance evidencé-based Intervention models designed to
promote long-term housing retention and mitigating associated health disparities within the homeless population.
Radical Acts to Survive (RATS) is a London-based drug user activist group unlon formed in 2024. Release solely provides fiscal sponsorship to this
group.
Trust for London (Legal) - The trust under their Decent Living Standards initlative is funding dellvery of a 3 year continuation and development
enhanced specialist social security legal advice service commencing from June 2021 for people who have a history of drug/alcohol dependency,
providing casework and representation at first tier and upper tribunal.
26 RELEASE LEGAL EMERGENCY AND DRUGS SERVICE LIMITED
NOTES TO THE FINANCIAL STATEMENTS
YEAR END 31 MARCH 2025
11a) RESTRICTED FUNDS - PREVIOUS YEAR
Lottery Fund
City Bridge Trust
Geneva Institute
I-Host
Justice Fellowship Fund
Legal Outreach Services
Trust for London
Balance
02-Ap-23
8,100
(57)
16,200
2,625
26,868
Income
€
109,960
18,000
12,858
40,000
246,108
34,925
461,850
Purchase of
Expenditure
Transfers in Transfers out
Fixed Assets
Balance
31-Mar-24
€
(103,299)
(8,100)
(12,858)
(40,000)
(231,876)
:
(34,355)
.. . .
18,300
18,000
(430,488)
11,696
30,432
3,195
69,927
2023/24: The transfers represent:
he restricted funds have been spent in accordance with the purpose they were given. The closing balance of restricted funds at 31st March 2025 an
1st March 2024 1s wholly represented by cash reserve:
12. ANALYSIS OF STAFF COSTS AND THE COST OF KEY PERSONNEL
Gross Wages and Salaries
Employer's Natlonal Insurance Cost
Less HMRC Incentive
2024/25
€
586,775
59,459
(5,000)
21,431
662.666
2023/24
€
574,908
57,688
(5,000)
14,589
642,185.
Number of employees who were employed:
2024/25
erenutes emotes during her
2023/24
1725
Staff are paid through the PAYE system.
Number of employees whose total employee benefits (excluding employer pension costs) fell within each band of £10,000 from £60,000 upwards:
Band
Number of employees
€60,000 to £69,999
€70,000 to f79,999
€80,000 to £89,999
£90,000 to £99,999
€100,000 to £109,999
The key management personnel of the charity comprise the Trustees, the Executive Director and the Head of Legal Services. No Trustees received
remuneration. The total employee benefits (including employer national insurance and employer pension contributions) of key management
• personnel of the charity was £69,525 (2023/24: £68,582).
The charity makes pension contributions for employees into individual personal pension plans. Contributions are charged to the Statement of Financia
Activitles as they become payable in accordance with the rules of the scheme. The amount charged in the financial year end 315t March 2025 wa
E21,428 (2023/24: £14,589). The charity is under no further obligation to make any extra payments irrespective of how that pension fund performs.
The assets of the scheme are held separately from those of the company in independently administered funds.
13. TRUSTEES AND OTHER RELATED PARTIES
2024/25
2023/24
Number of Trustees who were paid expenses
Total amount paid
€
No payments were made to Trustees or any persons connected with them during this financial period. No material transaction took place between the
organisation and a Trustee or any person connected with them.
27 RELEASE LEGAL EMERGENCY AND DRUGS SERVICE LIMITED
NOTES TO THE FINANCIAL STATEMENTS
YEAR END 31 MARCH 2025
14. MOVEMENT IN FUNDS - CURRENT YEAR
e Company is Limited by Guarantee (1966619) and is a Charity registered with the Charity Commission (801118) and does not have a Share capi
d has no income subject to Corporation T
Current vear movement in funds
Unrestricted Funds
General Funds
Designated Funds
334,729
36,763
(119,010)
(17,286)
(137)
137
Restricted Funds
Restricted Funds
69,927
TOTAL FUNDS
441,419
118,781
(17,515)
-
Net movement in funds, included in the above are as follows:
Income
Expenditure Movement
Unrestricted Funds
General Funds
Designated Funds
Restricted Funds
Restricted Funds
TOTAL FUNDS
14. MOVEMENT IN FUNDS - PRIOR YEAR
Comparatives for movement in funds
362,143
173,797
(481,153)
(191,083)
(119,010
(17,286
424,843
960,783
(306,062)
(978,298)
118,781
(17,515)
0LABn23
Netmunent Tranted bow
in funds
Unrestricted Funds
General Funds
Designated Funds
624,151
(196,489)
(44,474)
(92,933)
81,237
Restricted Funds
Restricted Funds
26,868
31,363
11,696
TOTAL FUNDS
651,019
(209,600)
Net movement in funds, included in the above are as follows:
Income
€
esperine Moverin
Unrestricted Funds
General Funds
Designated Funds
Restricted Funds
Restricted Funds
TOTAL FUNDS
117,443
80,166
(313,932)
(124,640)
(196,489
(44,474
461,851
659,460
(430,488)
7869,0607
215,582
19,614
188,708
423,904
32-Mar: 24
334,729
36,763
69,927
441,419
31,363
(209,600g
28 RELEASE LEGAL EMERGENCY AND DRUGS SERVICE LIMITED
NOTES TO THE FINANCIAL STATEMENTS
YEAR END 31 MARCH 2025
15. RISK ASSESSMENT
e Trustees actively review the major risks which the charity faces on a regular basis and believe that maintaining the free reserves stated, combin
th the annual review of the controls over key financial systems carried out on an annual bass will provide sufficient resources in the event of adve
conditions. The Trustees have also examined other operational and business risks which they face and confirm that they have establlshed systems to
16. RESERVES POLICY
The Trustees have considered the level of reserves they wish to retain, appropriate to the charity's needs. Further detail is provided in the Annual
report.
17. PUBLIC BENEFIT
18. EVENTS AFTER THE END OF THE REPORTING PERIOD
There are no events that require disclosure.
29 RELEASE LEGAL EMERGENCY AND DRUGS SERVICE LIMITED
STATEMENT OF CASHFLOWS
Cash used in operating activities
Cash used from investing activities
Interest income
Purpose of angle led ses
Case prosed by wed in.
Cash flows from financing activities
Introduction/(Repayment) of long term borrowing
Cash used in financing activities
here dense in ashand
star onese equivalents at the
total each an each euvalents
(a) Reconciliation of net movement in funds to net cash flow from operating activities
Net movement in funds
Add back depreclation charge
Deduct interest income shown
in investing activities
Decrease/(increase) in debtors
Increase/(decrease) in creditors
Decrease/(increase) in donated goods stock
Net cash used in operating activities
(b) Analysis of cash and cash equivalents
Cash at bank and in hand
Fixed Term Bond
Total cash and cash equivalents
(c) Analysis of net debt
At start
of year
134,492
:
Cash flows
Acquisition/
disposal of
subsidiaries
Cash
Cash Equivalents
Overdraft repayable on demand
Loans falling due < 1 yr
Loans falling due > 1 yr
Finance lease obligations
TOTAL
:
434,492
:
(88,200)
:
(a)
YEAR END 31 MARCH 2025
2024/25
(96,016)
2023/24
(157,579)
7,816
7,666
7,816
7,666
(b)
(88,200)
434,492
346,292
2024/25
€
(17,515)
4,137
(7,816)
(73,006)
(2,816)
(36,016)
2024/25
346,292
346,292
movements
finance
leases
:
...
•..
(149,913]
584,405
434,492
2023/24
€
(209,600)
20,127
(7,666)
29,908
9,652
(157,579)
2023/24
434,492
434,492
Foreign
exchange
:
:
At end
of year
346,292
346,292
30c.,,
RELEASE LEGAL Efy'IERGENCY AND DRUGS SERVICE LIMITED
CONTENTS
VEAR ENDED 31 MARCH 2025
Pages3 to 16
Trustees Annual Report
Page 17
Independent Examiners Report
Page 18
Statement of Financial Activities
Page 19
Balance Sheet
Page20to 29
Notes to the Financial Statements
Page30
Statement of Cashflows
TRUSTEE ANNUAL REPORT
RELEASE LEGAL EMERGENCY AND DRUGS SERVICE LIMITED
YEAR ENDED 31 MARCH 2025
YEAR ENDED 31 MARCH 2025
YEAR ENDED 31 MARCH 2025
MEMBERS OF THE BOARD AND PROFESSIONAL ADVISERS
MEMBERS OF THE BOARD AND PROFESSIONAL ADVISERS
MEMBERS OF THE BOARD AND PROFESSIONAL ADVISERS
REGISTERED CHARITY NAME
Release Legal Emergency and Drugs Service Limited
Release Legal Emergency and Drugs Service Limited
CHARITY NUMBER
801118
COMPANY REGISTRATION NUMBER
1966619
PRINCIPAL & REGISTERED OFFICE
36 Heneage Street
ADDRESS
Spitalflelds, London
El SU
TRUSTEES THAT SERVED DURING THE YEAR
Bisi Aklntoye
Natasha Dhumma
Roger Galland
Donnchadh Greene
James Hardy (Treasurer)
Peter Krykant
Amber Marksto 7th May 2024
David Rowntree
Profes or Toby Seddon
Iman! Robinson
TRUSTEES APPOINTED AFTER BALANCE SHEET DATE
Andrew Horne
from 23 September 2024
INDEPENDENT EXAMINER
Independent Examiners Ltd
The Grain Store, HIiis Barns
Appledram Lane South
Chichester
West Sussex
P0207EG
BANKERS
Co-operative Bank PLC
PO Box250
DelfHcuse
Skelmersdale
WN8 6WT
Charities Aid Foundation
25 Kings Hill Avenue
Kings HIii West Malling
Kent
ME194JQ
RELEASE LEGAL EMERGENCY AND DRUGS SERVICE LIMITED
TRUSTEE ANNUAL REPORT
YEAR ENDED 31 MARCH 2025
BOARD REPORT
Professor Toby Seddon Trustee Chairperson
RELEASE LEGAL EMERGENCY AND DRUGS SERVICE LIMITED
TRUSTEE ANNUAL REPORT
YEAR ENDED 31 MARCH 2025
Special Acknowledgement:
EXECUTIVE DIRECTOR REPORT
RELEASE LEGAL EMERGENCY AND DRUGS SERVICE LIMITED
TRUSTEE ANNUAL REPORT
YEAR ENDED 31 MARCH 2025
TRUSTEES (DIRECTORS) REPORT
FUNDS AND RESERVES
THE CHARITY'S ASSETS
RELEASE LEGAL EMERGENCY AND DRUGS SERVICE LIMITED
TRUSTEE ANNUAL REPORT
YEAR ENDED 31 MARCH 2025
INTERNSHIPS & VOLUNTEERING
MAIN RISKS
ORGANISATIONAL STRUCTURE
Board of
Release
11'111,!Mlll -111
. Niamh Eastwood
Ceecutive Owectes
— oe ome Pant Ing leet,
Cin Oates I· = ;=e• : Cor
posed , [2] batats Overs rane hey Re
C:14
——
Paey oemaco
Lepl Vowntul5/lnterns Hann ReducUon Hub ,
.._
.... .......
----- End of picture text -----RELEASE LEGAL EMERGENCY AND DRUGS SERVICE LIMITED
TRUSTEE ANNUAL REPORT
YEAR ENDED 31 MARCH 2025
Release takes decisions through regular meetings as follows:
APPOINTMENT OF TRUSTEES
, FINANCIAL STRATEGY
RELEASE LEGAL EMERGENCY AND DRUGS SERVICE LIMITED
TRUSTEE ANNUAL REPORT
YEAR ENDED 31 MARCH 2025
RESULTS (excluding restricted funds)
PUBLIC BENEFIT
ACTIVITIES AND REVIEW OF THE VEAR
RELEASE LEGAL EMERGENCY AND DRUGS SERVICE LIMITED
TRUSTEE ANNUAL REPORT
OUR WORK {United Kingdom)
ADVICE & REPRESENTATION SERVICES LEGAL OUTREACH SERVICES
Legal Services Development
TRUSTEE ANNUAL REPORT
YEAR ENDED·31 MARCH 2025
DRUGS SERVICES
Harm Reduction Hub.
Advocacy
Project work
RELEASE LEGAL EMERGENCY AND DRUGS SERVICE LIMITED
TRUSTEE ANNUAL REPORT
YEAR ENDED 31 MARCH 2025
NATIONAL LEGAL AND DRUGS HELPLINE
RESEARCH & POLICY
Research into the experiences of people who use drugs and are unhoused
Wider policy and research work
RELEASE LEGAL EMERGENCY AND DRUGS SERVICE LIMITED
TRUSTEE ANNUAL REPORT
YEAR ENDED 31 MARCH 2025
RELEASE WEBSITE AND SOCIAL MEDIA PLATFORMS
OUR WORK (INTERNATIONAL)
Fellowship Programme
Expert NGO Support
TALKING DRUGS
RELEASE LEGAL EMERGENCY AND DRUGS SERVICE LIMITED
TRUSTEE ANNUAL REPORT
Active users,. by Country
----- End of picture text -----YEAR ENDED 31 MARCH 2025
COUNTRY ACTIVE USERS
-.... ---- .. - . ···················
Russia 21K
coon United States 17K
Japan 16K
United Kingdom 16K
Germany 11K
—
Poland 9.4K
Italy 5.6K
----- End of picture text -----MEDIA WORK
EVENTS, CONFERENCES AND SEMINARS
CYBER SECURITY
DONORS
RELEASE LEGAL EMERGENCY AND DRUGS SERVICE LIMITED
TRUSTEE ANNUAL REPORT
RELEASE LEGAL EMERGENCY AND DRUGS SERVICE LIMITED
TRUSTEE ANNUAL REPORT
YEAR ENDED 31 MARCH 2025
RESPONSIBILmES OF THE TRUSTEES
RELEASE LEGAL EMERGENCY AND DRUGS SERVICE LIMITED
INDEPENDENT EXAMINERS REPORT
YEAR ENDED 31 MARCH 2025
RELEASE LEGAL EMERGENCY AND DRUGS SERVICE LIMITED
BALANCE SHEET
Company registration no: 1966619
Company registration no: 1966619
Company registration no: 1966619
Note
Unrestricted
Funds·
£Designated
Funds
£Restricted
Funds
£31-Mar-25
Total
£31-Mar-24
Total
£
Fixed As ets
Tangible assets
6
8,273
8,273
12,410
Current Assets
Cash at bank and In hand
Debtors
Total Current As ets7
8137,970
94,830
232,80019,614
19,614188,708
188,708346,292
94,830
441,122434,492
21,824
456,316
Creditors: amounts falling due within one year
9
25,491
25,491
27,307
NET CURRENT AS ETS
207,309
19,614
188,708
415,631
429,009
TOTAL AS ETS less current liabilities
215,582
19,614
188,708
423,904
441,419
NET AS ETS
2:1:S,SB:Z
l!J,614
IB ,7DB
ffl,9D4
Ul,419
Funds of the Charity
General Funds
215,582
215,582
334,729
Designated Funds
Restricted Funds10
11
19,614
188,708
19,614
188,70836,763
69,927
Total Funds
zB,SS:Z
l!J,614
IBB,7oB
42.3,9D4
Ul,419
Directors' Responsibilities:
Approved by the Directors on the Signed on their behalf by Directoree